Cell and Tissue Preservation Market Size Worth Around US$ 8.52 BN by 2029

The cell and tissue preservation market was valued at US$ 3.56 billion in 2021 and is estimated to worth around US$ 8.52 billion by 2029 with a CAGR of 11.6% from 2022 to 2030.

The cell and tissue preservation market was valued at US$ 3.56 billion in 2021 and is estimated to worth around US$ 8.52 billion by 2029 with a CAGR of 11.6% from 2022 to 2030.

Demand for cell and tissue preservation remains strong in 2021. Some sales insight revealing the strong growth of cell and tissue preservation during the past few years are listed below:

  • The global cell and tissue preservation market size is expected to reach a value of US$ 9.54 billion by 2030
  • By type, the tissue segment captured a market share of 52% in 2021
  • The tissue segment is expected to grow at a CAGR of 11.7% from 2022 to 2030
  • By application, the therapeutics segment constituted 40% of the global revenues in 2021
  • Therapeutics segment is expected to grow at a CAGR of 11.8% from 2022 to 2030
  • By product, the equipment segment generated a revenue of US$2,026 million in 2021
  • By end user, the biobanks segment accounted for a revenue share of 68% in 2021

Get the sample copy of report@ https://www.precedenceresearch.com/sample/1642

The rising penetration of the biobanks, rising investments by the pharma companies in the research and development to indulge in drug discovery and development activities for introducing various latest and innovative drugs to treat diseases such as Alzheimer’s disease, Parkinson’s disease, cancer, and diabetes has significantly driven the growth of the cell and tissue preservation market in North America. The rising adoption of the digital technologies in the biobanks in North America is expected to have a significant impact of the market growth in the forthcoming years. North America is characterized by the rising penetration of biobanks and presence of several leading pharmaceutical companies that are supported by the government authorities in developing various new therapies and drugs. The rising investments and rising need for understanding the origin of various diseases, the preservation of cell and tissue is necessary. Thus, the high expenditure on the study of cell and tissues in North America has resulted in the growth of the North America cell and tissue preservation market.

Report Scope

Details

Market Size in 2021

USD 3.56 Billion

Growth Rate from 2022 to 2030

CAGR of 11.6%

Base Year

2021

Forecast Period

2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Ask here for customization@ https://www.precedenceresearch.com/customization/1642

What are the key trends in the Global Cell and Tissue Preservation Market?

Significantly rising investments by the research communities and companies to enhance the capabilities and offer improved services and products are creating lucrative growth opportunities. For example, the development of Cooperative Human Tissue Network (CHTN) that expresses the operational dimension of the biobanks. Moreover, the rising healthcare expenditure across the globe is expected to provide access to the quality and advanced healthcare and products, which has bio-preservation facilities. The biobanks, hospitals, and gene banks are among the major end users of cell and tissue preservation market that encourage the market players to introduce advanced bio-preservation solutions to improve the patient results. Furthermore, the emergence of the virtual biobanks is an emerging trend in the global cell and tissue preservation market. The virtual biobanks allow the researchers to conduct research studies smoothly and timely, which is expected to boost the demand for the cell and tissue preservation across the globe.

What are the key challenges in the Global Cell and Tissue Preservation Market?

The operational costs of storing and preserving the cell and tissues are high. The cost of the consumables and equipment used in the biobanks is very costly and hence the cell and tissue preservation market may face challenges due to the high costs associated. Further, there is a lack of ethics in the developing countries. Lack of ethical implication of storing and distributing the cell and tissues may restrict the growth of the global cell and tissue preservation market during the forecast period.

Asia Pacific Forecast the Strongest Growth Rate of XX% during the Forecast Year (2022-2030)

Asia Pacific is the home to several top research institutes and organizations. The leading pharma companies invest heavily in Asia Pacific owing to the availability of skilled researchers at affordable costs and other factors of production. Therefore, the establishment costs of biobanks are comparatively low in Asia Pacific. Moreover, the growing prevalence of various chronic diseases and rising demand for the innovative and effective drugs at affordable costs is driving the growth of the cell and tissue preservation market in the Asia Pacific region. The rising government investments in the development of strong digital and healthcare infrastructure is expected to support the market growth during the forecast period.

Related Reports

Top Cell and Tissue Preservation Market Players in 2020

Thermo Fisher Scientific, Inc., Lonza, BD, MerckKGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, and CellGenix GmbH are some of the market players operating in the global cell and tissue preservation market.

Market Segmentation

By Type

  • Cell
    • Mammalian Cells
    • Others (Microorganisms and Plant Cells)
  • Tissue
    • Blood
    • Bone
    • Soft Tissues
    • Skin
    • Others

By Application

  • Therapeutics
  • Drug Discovery
  • Gene therapy
  • IVF treatment
  • Cell therapy
  • Research & Development

By Product

  • Equipment
    • Freezers
    • Refrigerators
    • Storage Systems
    • Others
  • Software
  • Bio-preservation Media
    • Home-brew Media
    • Pre-formulated Media

By End User

  • Biobanks
  • Hospitals

By Cell Provider

  • CD34+
  • CD19+
  • MSC
  • iPSC
  • hESC
  • Tumor Cells
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Click Here to View Full Report Table of Contents

Buy this Research Report@ https://www.precedenceresearch.com/checkout/1642

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333